Dr. Brodowski advises clients in connection with the creation, protection and exploitation of patent and other IP rights in the U.S. and abroad in key marketplaces to support the clients’ business objectives. He has extensive experience and knowledge in post-grant proceedings including patent reexamination, reissue and foreign opposition proceedings. Dr. Brodowski also counsels clients in avoiding competitors’ patent rights including freedom-to-operate studies. In addition, he drafts and negotiates patent license and other technology-related agreements; prepares patent opinions regarding infringement and invalidity; and conducts IP due diligence and audits for public and private business transactions including drafting patent opinions and prospectus language. He also assists patent litigation counsel.
Dr. Brodowski advises clients in the fields of chemistry including pharmaceuticals, plastics and polymers, drug delivery technologies, specialty chemicals and chemical manufacturing; materials science and nanotechnology including composite materials; energy including petroleum processing, fuel cells, solar cells and biofuels; biotechnology; and health care including diagnostic assays, medical devices and personal care products.
Dr. Brodowski is a member of the Massachusetts Bar Association, the Boston Patent Law Association, and the American Chemical Society (Division of Chemistry and the Law).
Prior to joining Goodwin in 2016, he was a partner in the patent and IP practice groups at Burns Levinson LLP, K&L Gates LLP and Testa, Hurwitz & Thibeault LLP. Prior to entering the legal profession, Dr. Brodowski was a Project Chemist in the Product Development Group of the Toiletries Technology Laboratory at The Gillette Company. He is the first named inventor on issued U.S. and foreign patents. His doctorate studies included the multistep synthesis of the top half of the macrolide antibiotic, chlorothricolide, using vitamin C as the starting material.